GLP-1 medications for weight loss are all the rage, but they come with some side effects. Here are my top 10 supplements I take everyday while on Zepbound.

In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicines that include Ozempic, was cleared to treat moderate to severe OSA in individuals ...

GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes medication has become not only a household name but ...

People using GLP-1 medications aren’t just ‘taking the easy way out.’ You’ve probably seen someone online make the accusation, so-and-so lost weight, they must be taking Ozempic — cheater.

It’s orforglipron, a different GLP-1 from Wegovy’s semaglutide or Zepbound’s tirzepatide. An oral semaglutide option has already been a key factor in Hims & Hers’ sales demand, that firm ...

Zepbound is the first and only FDA-approved dual glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) obesity medication.

The mean baseline blood insulin levels (expressed in µU/mL) were 11.2±4.1 for injected Zepbound® and 12.0±6.1 for oral DehydraTECH- tirzepatide, compared to the ending levels of 16.2±6.2 and ...

Men's big-and-tall retailer DXL is expecting, perhaps ironically, to benefit from the popularity of GLP-1 drugs such as Ozempic and Zepbound. J.Jill plans to open up to 25 new stores next year ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.

The mean baseline blood insulin levels (expressed in µU/mL) were 11.2±4.1 for injected Zepbound® and 12.0±6.1 for oral DehydraTECH- tirzepatide, compared to the ending levels of 16.2±6.2 and ...